Search | Page 20 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Clinical Utility of Lenalidomide in the Treatment of Myelodysplastic Syndromes

    ... to examine the combination of hypomethylating agent azacitidine and lenalidomide. The verdict is still out whether regarding ...

    Research Review last updated 05/02/2016 - 9:12am.

  2. Clinical Trial Basics

    ... (Revlimid) eculizumab (Soliris) azacitidine (Vidaza) eltrombopag (Promacta) Research ...

    Page last updated 03/29/2016 - 7:29pm.

  3. FAQs

    ... (Revlimid), decitabine (Dacogen) and azacitidine (Vidaza). Chemotherapy treats MDS by using drugs ... (Revlimid®) decitabine (Dacogen®) and azacitidine (Vidaza®). Learn more about treatments for MDS. For PNH ...

    Topic section last updated 03/02/2016 - 11:42am.

  4. Biting into the Elephant

    ... hope in my physician. We formulated our plan which was azacitidine (Vidaza®) treatment followed by a stem cell transplant ...

    Patient Chronicle last updated 06/27/2016 - 2:22pm.

  5. Clinical Trials Report for November 2015

    ... Efficacy and Safety Study of CC-486 (ORAL AZACITIDINE) in Subjects With Myelodysplastic Syndromes The primary ... study is to Evaluate the efficacy and safety of CC-486 (ORAL AZACITIDINE) in subjects with myelodysplastic syndromes. This study is ...

    Page last updated 10/30/2015 - 8:46am.

  6. Clinical Trials Report for October 2015

    ... Efficacy and Safety Study of CC-486 (ORAL AZACITIDINE) in Subjects With Myelodysplastic Syndromes The primary ... study is to Evaluate the efficacy and safety of CC-486 (ORAL AZACITIDINE) in subjects with myelodysplastic syndromes. This study is ...

    Page last updated 09/30/2015 - 10:53am.

  7. Patient Education Materials

    ... treatments using the 3 FDA-approved drugs for MDS – azacitidine (Vidaza®), decitabine (Dacogen®) and lenalidomide ...

    Page last updated 11/06/2013 - 4:28pm.

  8. Nursing Education Modules on MDS Disease Management and Patient Education

    ... chelation Treatment options for high-risk MDS – azacitidine , decitabine , allo-HSCT, clinical trials MDS ...

    Page last updated 04/27/2015 - 2:44pm.

  9. Aristoteles Giagounidis, MD

    ... approaches. These include lenalidomide and azacitidine in myelodysplastic syndromes, deferasirox in iron ...

    Page last updated 01/20/2012 - 3:30pm.

  10. Clinical Trials Report for January 2015

    ... Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS) The goal of ... study is to compare how 2 different drugs, decitabine and azacitidine, when given on a shorter than standard dosing schedule, may help to ...

    Page last updated 12/30/2014 - 10:45am.